Skip to main content

Table 3 Univariate analysis of patient characteristics between the postanesthetic shivering (PAS) group and non-postanesthetic shivering (non-PAS) group

From: Efficacy of flurbiprofen axetil for preventing postanesthetic shivering in patients undergoing gynecologic laparotomy surgeries

 

PAS group (n = 30)

Non-PAS group (n = 111)

p value

Age (year)

41 ± 9 (24-67)

51 ± 13 (21-84)

< 0.001

Body mass index (kg/m2)

23.3 ± 3.9 (17.4-36.0)

23.8 ± 5.0 (16.0-46.1)

0.774

Co-morbidities

 Hypertension

4 (13.3)

22 (19.8)

0.416

 Diabetes mellitus

1 (3.3)

7 (6.3)

0.532

 Bronchial asthma

4 (3.3)

15 (13.5)

0.195

Malignancy

13 (43.3)

57 (51.3)

0.976

Operation time (min)

166 ± 75 (75-356)

137 ± 49 (47-319)

0.096

Anesthesia time (min)

233 ± 92 (114-458)

198 ± 54 (103-381)

0.103

Blood loss (g)

723 ± 837 (10-3519)

376 ± 418 (5-2316)

0.093

Fluid infusion (ml/kg/h)

8.8 ± 2.9 (3.6-14.2)

9.0 ± 3.2 (3.4-16.7)

0.924

Fentanyl dosage (μg/kg)

4.2 ± 1.8 (1.6-9.8)

4.7 ± 1.7 (0.9-10.9)

0.273

Remifentanil dosage (mg)

2.4 ± 1.2 (0.8-6.0)

1.8 ± 0.8 (0.8-6.0)

0.015

Body temperature (°C)

 Highest body temperature

36.8 ± 0.3 (36.3-37.4)

36.8 ± 0.4 (35.8-38.0)

0.635

 Lowest body temperature

36.2 ± 0.5 (35.1-37.0)

36.3 ± 0.4 (35.1-37.3)

0.549

Epidural analgesia

29 (96.7)

98 (88.3)

0.173

Flurbiprofen axetil

2 (6.7)

29 (26.1)

0.022

  1. PAS postanesthetic shivering
  2. The data are given as patient’s number (%) or the mean ± standard deviation (range)